Other women report becoming pregnant while using injectable pens for weight loss. (Photo: Reproduction)
A woman, living in Florida, in the United States, became pregnant two weeks after starting to use the Mounjauro injectable pen. Marcela Romero, who had been trying to get pregnant for at least three years, considered in vitro fertilization (IVF), but was surprised by the news that she would be a mother.
Monjauro (with tirzepatide as an active ingredient), manufactured by the pharmaceutical company Eli Lilly, was originally developed for the treatment of type 2 diabetes, but is used off-label (a purpose other than the leaflet) for weight loss, as is Ozempic (with semaglutide as the active ingredient), manufactured by Novo Nordisk.
However, Romero is not the only one to report the side effect of heightened fertility. Other women in the United States report becoming pregnant while using injectable pens for weight loss. A Facebook group called “I got pregnant with Ozempic” has more than 450 members, in addition, netizens have shared on other platforms about how they unexpectedly got pregnant while taking Ozempic.
“I got pregnant taking Ozempic and I was on the pill! The baby will be born in June,” one person commented on a TikTok video.
According to the U.S. Office on Women’s Health, Monjauro has already been prescribed for polycystic ovary syndrome (PCOS), a hormonal disorder that affects women of childbearing age and increases the risk of premature birth and miscarriage. Additionally, recent research has linked tirzepatide to estrogen regulation.
